Articles On Global Health (ASX:GLH)

The interest rate rise came and the markets fell, then turned a corner. The question now is — will the wheels stay on? Already lagging, the ASX Emerging Companies (XEC) index has closed 0.8% lower. The benchmark has closed 0.4% behind. The...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Opyl’s contracts with two new clinical trial customers have validated the company’s pivot to focus on AI technology and its recruitment platform, Opin. Digital health company Opyl (ASX:OPL) has just signed two new clinical trial recruitment...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two million people. Treasurer Josh Frydenberg announced last night that Australia’s health budget will top $132bn in 2022-23, up from $62bn a decade...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

Exchange Traded Funds (ETFs) on the ASX have grown to a $126.9 billion industry. Here’s a guide on the ASX ETF sector and what investors need to know.    Key points ETFs are managed funds, listed on stock exchanges that invest in various f...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Highlights Telehealth companies allow patients to connect with their doctors and medical practioners via phone, messages, or video conference. COVID-19 pandemic gave a boost to the demand for telehealth services. DOC and GLH are two p...

Many sectors of society might have come to a complete halt during COVID-19 if it was not for innovative solutions from the tech industry, which will last well beyond the pandemic. As governments worldwide have been forced to protect public...

Dimerix’s lead drug candidate DMX-200 has been given regulatory green light for approval for a Phase 3 study in COVID-19 ravaged India. Clinical-stage biotech Dimerix (ASX:DXB)  has received approval from the review committee in India for...

Shares in Dimerix Ltd (ASX: DXB) are soaring today, shooting up 9% in early trade. At the time of writing, the Dimerix share price has retreated slightly and is now trading at 30 cents apiece, up 7.4%. Below we take a look at the clinical-...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

23 Aug 2021 - Global Health Care giant Sonic Healthcare (ASX:SHL), delivered significant revenue and earnings for the period ending 30 Jun 2021, amid the Covid-19 pandemic.

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

The ASX ended the week on a high note, finishing up 0.13 per cent with most sectors in positive territory. The index touched a record high of 7,334 today but failed to keep the momentum and eventually closed at 7,312. For the week, the inde...

The ASX had a positive trading day finishing nearly 0.5 per cent up with almost all sectors in positive territory. The ASX 200 closed at 7,303 – 0.44 per cent higher than yesterday while the ASX Emerging Companies Index rose over 1 per cent...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Biotech Global Health (ASX:GLH) topped this week’s Running Hot list, in the wake of more steady gains in May which has seen its share price rise by almost 500 per cent over the past 12 months. Each week, Stockhead recaps ASX stocks that are...

Last year's pandemic put the focus firmly on telehealth services providers, but share prices have deflated since as investors started asking questions, and on the general realisation telehealth has its limits too. -Covid-19 triggered a rush...

If you thought the COVID-19 telehealth boom was big, you ain’t seen nothing yet. Telehealth adoption in Australia and around the globe exploded last year due to COVID-19. Specifically, many patients requiring health services were left no ot...

Summary With the current emergency, it is anticipated that telehealth or telemedicine could be the future of medicine. COVID-19 pandemic resulted in considerable adoption of telehealth solutions, mainly to avoid physical contact. The...

Stockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the level at which a company may have been...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Source: ShutterstockProfessional ,Shutterstock Summary 88 Energy has been catching attention since early trading hours, notching up by 25 per cent. Cryosite’s share price is up by 20.5 per cent at A$0.205 after the company announced i...

The Dimerix Ltd (ASX: DXB) share price is rising today after the biopharmaceutical company announced its involvement in a trial on COVID-19 therapies. Dimerix will be involved in the trial, named CLARITY 2.0, which has received approval fr...

Summary Amid growing adoption of digital platforms, Global Health registered a robust half-year performance. Total customer revenue for the period was up by 20% on PCP. The MasterCare platform for community health care providers exper...

Summary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health delivery organisations have embraced digital engagement with patients. Lifecard Patient Portal assists consumers and doctors in managing d...

The Global Health Limited (ASX: GLH) share price is lifting higher today after the company announced it was experiencing strong demand for its Lifecard Patient Portal. At the time of writing, the Global Health share price is up 1.12% at 45...

The Dimerix Ltd (ASX: DXB) share price lifted higher today after the company announced the start of its second clinical study on lead drug candidate, DMX-200. At the time of writing, the Dimerix share price is up 6.1% at 26 cents. What’s d...

Summary eSense is working towards developing a superior organic sanitiser providing extra protection against bacteria and viruses. The Company tested two proprietary terpenes profiles, TRP-ENV and TRP-COV, to ascertain their anti-viral...

Summary As of 18 November 2020, Asia has 9.8 million ‘reported’ cases and 161,000 deaths. Countries are now trying their best to control the spread of the virus and heal those that are already infected. Restricted or complete lockdown...

Global Health Limited (ASX: GLH) shares rocketed up in early trade today after the announcement of a major contract win with the Western Australian Government. Before the market halt this morning, the Global Health share price was trading...

The Global Health Limited (ASX: GLH) share price is on the rise today after the company released a positive announcement regarding a significant contract win. In early morning trade, shares in the digital health company were down 6.5% to 3...

The 11 startups the UNSW Founders invested in as part of its 2020 10x accelerator program make their public debut over the coming week as part of two Demo Nights. The first, the 10x Demo Night, is this afternoon, October 28. The 2020 cohort...

The Global Health Limited (ASX: GLH) share price has rocketed higher following the release of a trading update for FY21. On the opening bell, shares in the med tech company lifted 38% to 47 cents from the news. However, its shares have sli...

Global Health Limited (ASX: GLH) has been developing software for the healthcare industry for more than 30 years. Today it announced a new partnership between the company’s Lifecard consumer health platform with Asthma Australia. The news...

The share price of Australian healthcare software provider Global Health Ltd [ASX:GLH] has rocketed up today after partnering with Asthma Australia. At the time of writing, the GLH share price are up ~70%, or 16 cents, to trade at 39 cents...